RESEARCH PAPER
Pharmacological modulation of CXCL12/CXCR4/ACKR3 for brain disorders - an overview.
AI Summary
A review of pharmacological modulation of the CXCL12 chemokine axis (CXCR4/ACKR3) in brain disorders, describing receptor signaling, pathophysiological roles, and available modulators.
Why It Matters
The CXCL12/CXCR4/ACKR3 axis links to neuroinflammation, neuroprotection, BBB integrity and has existing drugs (e.g., CXCR4 antagonists) that could be repurposed for Parkinson's-related neuroinflammatory or neuroprotective strategies, but the paper appears to be a broad review with no PD-specific…